Cargando…
Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury
Autores principales: | Mizrahi, Jonathan D., Overman, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201853/ https://www.ncbi.nlm.nih.gov/pubmed/30405879 http://dx.doi.org/10.18632/oncotarget.26207 |
Ejemplares similares
-
Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
por: Zhu, Chen, et al.
Publicado: (2022) -
Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
por: Kobayashi, Shinichiro, et al.
Publicado: (2019) -
Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome
por: Saito, Rika, et al.
Publicado: (2022) -
Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy
por: Seo, An Na, et al.
Publicado: (2014) -
Focal Sinusoidal Obstruction Syndrome Caused by Oxaliplatin-Induced Chemotherapy: A Case Report
por: Kawai, Takaharu, et al.
Publicado: (2016)